A lot of things need to go right on a molecular level for immune cells to launch an adaptive response to an infection. B cells can produce different classes of antibodies tailored for specific ...

Building upon a deep understanding of immune cell activation, researchers from Children's Hospital of Philadelphia (CHOP) developed a new artificial platform that can be used to induce T cell ...

Zoonotic pathogens represent a growing global risk, yet the speed of adaptive immune activation across mammalian species remains poorly understood. Despite orders-of-magnitude differences in size and ...

Immune response during the progression of premalignant lesions and their molecular subtype to colorectal cancer (CRC) remains unclear. Using gene expression data from 135 normal (NLs), 176 ...

It's a virus that can strike with unrelenting force. The kind of care need to knock it out is often not fully available in a lower resource country like the Democratic Republic of Congo.

Arachnology and toxinology have increasingly illuminated the structural, biochemical and evolutionary diversity of venom ...

Autoimmune and autoinflammatory diseases have traditionally been interpreted as disorders arising from dysregulation of adaptive or innate immune responses, ...

Scientists generally agree that eukaryotes, the domain of life whose cells contain nuclei and that includes almost all multicellular organisms, originated from a process involving the symbiotic union ...

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic. In the years that followed, other groups ...

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Executive Officer and Co-Founder Chad Robins said the company is focused on expanding its minimal residual disease testing business while pursuing targeted ...

Adaptive Biotechnologies attracts attention as immune medicine innovation, diagnostic advancements, and biotechnology ...